Titlebook: Comprehensive lipid testing and management; Lars A. Carlson Book 2011 Springer Healthcare 2011 Cholestrol.Coronary heart disease.Diabetes.

只看該作者 · 發(fā)表于 2025-3-25 13:27:21

Drugs for lipid managementt-line treatment, however, it may well have to be combined with other. Lipid management drugs depending on the type of dyslipidaemia and the response to statins. It is worth noting that there is a residual risk after treatment with statins of clinical atherosclerosis events that varies between 40–60%.

只看該作者 · 發(fā)表于 2025-3-25 18:54:59

Book 2011as the goals of treatment and pharmacological management of lipid levels.The book is divided into two parts, one covering lipid testing and one covering lipid management in the prevention of cardiovascular disease.

只看該作者 · 發(fā)表于 2025-3-25 21:55:54

只看該作者 · 發(fā)表于 2025-3-26 02:25:56

只看該作者 · 發(fā)表于 2025-3-26 04:34:51

https://doi.org/10.1007/978-1-908517-33-3Cholestrol; Coronary heart disease; Diabetes; Lipids; Statins

只看該作者 · 發(fā)表于 2025-3-26 10:48:15

只看該作者 · 發(fā)表于 2025-3-26 15:09:26

Lars A. CarlsonWritten by a leading and highly respected expert in the field.Concise pocket-sized format.Particularly aimed at cardiologists, clinical researchers, general practitioners, and primary care physicians.

只看該作者 · 發(fā)表于 2025-3-26 19:45:59

http://image.papertrans.cn/c/image/231972.jpg

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網	吾愛論文網	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經驗總結	SCIENCEGARD	IMPACTFACTOR	派博系數	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-12 03:38
Copyright © 2001-2015 派博傳思京公網安備110108008328 版權所有 All rights reserved